Financial reports
Current reports
6-K
Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
10 Apr 24
6-K
Current report (foreign)
6 Mar 24
6-K
Pharvaris Announces Extraordinary Meeting of Shareholders
16 Feb 24
6-K
Registration Rights Agreement
7 Feb 24
6-K
Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks
22 Jan 24
6-K
Current report (foreign)
8 Jan 24
6-K
Current report (foreign)
8 Dec 23
6-K
Current report (foreign)
6 Dec 23
6-K
Pharvaris Reports Third Quarter 2023 Financial Results and Provides Business Update
2 Nov 23
6-K
Pharvaris Reports Second Quarter 2023 Financial Results and Provides Business Update
7 Aug 23
Registration and prospectus
F-3ASR
Automatic shelf registration (foreign)
12 Apr 24
F-3ASR
Automatic shelf registration (foreign)
6 Mar 24
424B5
Prospectus supplement for primary offering
7 Dec 23
FWP
Free writing prospectus
6 Dec 23
424B5
Prospectus supplement for primary offering
24 Aug 23
F-3
Shelf registration (foreign)
7 Aug 23
424B5
Prospectus supplement for primary offering
15 Mar 22
F-3
Shelf registration (foreign)
1 Mar 22
S-8
Registration of securities for employees
9 Feb 21
424B4
Prospectus supplement with pricing info
8 Feb 21
Proxies
No filings
Other
EFFECT
Notice of effectiveness
17 Aug 23
CORRESP
Correspondence with SEC
15 Aug 23
UPLOAD
Letter from SEC
14 Aug 23
EFFECT
Notice of effectiveness
11 Mar 22
CORRESP
Correspondence with SEC
8 Mar 22
UPLOAD
Letter from SEC
3 Mar 22
EFFECT
Notice of effectiveness
5 Feb 21
CERT
Certification of approval for exchange listing
4 Feb 21
SEC STAFF
SEC staff action: Order
4 Feb 21
CORRESP
Correspondence with SEC
2 Feb 21
Ownership
144
Notice of proposed sale of securities
15 Apr 24
144
Notice of proposed sale of securities
10 Apr 24
144
Notice of proposed sale of securities
15 Mar 24
144/A
Notice of proposed sale of securities (amended)
15 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
144
Notice of proposed sale of securities
13 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
144
Notice of proposed sale of securities
15 Feb 24
SC 13G/A
Venrock Healthcare Capital Partners III, L.P.
14 Feb 24
SC 13G/A
VIKING GLOBAL INVESTORS LP
14 Feb 24